• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆传播的耐碳青霉烯肺炎克雷伯菌暴发:耐药基因及头孢他啶-阿维巴坦敏感性评估

Carbapenem-resistant Klebsiella pneumoniae outbreak with monoclonal spread: Evaluation of resistance genes and ceftazidime-avibactam susceptibility.

作者信息

Arıcı Neslihan, Tanrıverdi Elif Seren, Çalık Şeyma, Kansak Nilgün, Adaleti Rıza, Otlu Barış, Aksaray Sebahat

机构信息

University of Health Sciences, Haydarpasa Numune Research and Training Hospital, Medical Microbiology, Istanbul, Turkey.

Inonu University, Medical Faculty, Department of Medical Microbiology, Malatya, Turkey.

出版信息

Indian J Med Microbiol. 2023 Nov-Dec;46:100431. doi: 10.1016/j.ijmmb.2023.100431. Epub 2023 Jul 27.

DOI:10.1016/j.ijmmb.2023.100431
PMID:37945124
Abstract

PURPOSE

The aim of this study was to investigate ceftazidime-avibactam (CAZ-AVI) susceptibility, carbapenemase genes, and clonal relationship in carbapenem-resistant Klebsiella pneumoniae (CrKp) isolates.

METHODS

A total of 28 non-repetitive CrKp isolates with positive carbapenemase production determined by the modified carbapenem inactivation method (mCIM), were included in the study. Identification of the isolates was performed with MALDI-TOF MS (VITEK-MS, bioMerieux, France). The automated system (VITEK-2, bioMerieux) and gradient diffusion test (Etest, bioMerieux) were used to determine antibiotic susceptibility. The mCIM was performed according to CLSI (2021) recommendations. CAZ-AVI susceptibility was carried out using the standard disc diffusion method. Results were evaluated according to EUCAST 2022 criteria. The bla, bla, bla, bla and bla genes were investigated by multiplex PCR. The clonal relationship between isolates was determined by both AP-PCR and PFGE methods.

RESULTS

Of the total 28 isolates, 89.3% were susceptible to CAZ-AVI. bla gene was found in 85.7% of the isolates, bla+bla gene in 10.7%, and bla gene in 3.6%. bla, bla and bla genes were not detected. Three clusters with three different genotypes were determined by the PFGE method. The largest cluster was Genotype A (n:24), followed by Genotype B (n:3), and Genotype C (n:1). AP-PCR was highly compatible with PFGE. The isolates of Genotype A, mostly from the intensive care unit (ICU), were evaluated as outbreak strains with monoclonal dissemination.

CONCLUSIONS

OXA-48 remains the most frequently detected enzyme in CrKp strains in our country. The ceftazidime-avibactam susceptibility rate of 89.3% indicates that this antibiotic is still effective against CrKp isolates. The unnoticed outbreak detected in our study revealed the severity of intra-hospital cross-contamination affecting different wards, including the ICU. Therefore, in order to limit the spread of CrKp isolates, it is of great importance to implement strict infection control measures, and molecular surveillance programs, especially in the ICU.

摘要

目的

本研究旨在调查耐碳青霉烯类肺炎克雷伯菌(CrKp)分离株对头孢他啶-阿维巴坦(CAZ-AVI)的敏感性、碳青霉烯酶基因及克隆关系。

方法

本研究纳入了28株经改良碳青霉烯灭活法(mCIM)检测碳青霉烯酶产生呈阳性的非重复CrKp分离株。采用基质辅助激光解吸电离飞行时间质谱(VITEK-MS,法国生物梅里埃公司)对分离株进行鉴定。使用自动化系统(VITEK-2,生物梅里埃公司)和梯度扩散试验(Etest,生物梅里埃公司)测定抗生素敏感性。mCIM按照美国临床和实验室标准协会(CLSI,2021年)的建议进行。采用标准纸片扩散法检测CAZ-AVI敏感性。结果根据欧洲药敏试验委员会(EUCAST,2022年)标准进行评估。通过多重聚合酶链反应(PCR)检测bla、bla、bla、bla和bla基因。采用任意引物聚合酶链反应(AP-PCR)和脉冲场凝胶电泳(PFGE)方法确定分离株之间的克隆关系。

结果

在28株分离株中,89.3%对CAZ-AVI敏感。85.7%的分离株中检测到bla基因,10.7%的分离株中检测到bla+bla基因,3.6%的分离株中检测到bla基因。未检测到bla、bla和bla基因。通过PFGE方法确定了具有三种不同基因型的三个聚类。最大的聚类是基因型A(n = 24),其次是基因型B(n = 3)和基因型C(n = 1)。AP-PCR与PFGE高度一致。基因型A的分离株大多来自重症监护病房(ICU),被评估为单克隆传播的暴发菌株。

结论

OXA-48仍然是我国CrKp菌株中最常检测到的酶。89.3%的头孢他啶-阿维巴坦敏感性率表明该抗生素对CrKp分离株仍然有效。我们研究中发现的未被注意到的暴发揭示了影响包括ICU在内的不同病房的医院内交叉污染的严重性。因此,为了限制CrKp分离株的传播,实施严格的感染控制措施和分子监测计划非常重要,尤其是在ICU。

相似文献

1
Carbapenem-resistant Klebsiella pneumoniae outbreak with monoclonal spread: Evaluation of resistance genes and ceftazidime-avibactam susceptibility.单克隆传播的耐碳青霉烯肺炎克雷伯菌暴发:耐药基因及头孢他啶-阿维巴坦敏感性评估
Indian J Med Microbiol. 2023 Nov-Dec;46:100431. doi: 10.1016/j.ijmmb.2023.100431. Epub 2023 Jul 27.
2
Diversity of carbapenemase genes among carbapenem resistant Klebsiella pneumoniae in a tertiary care hospital in Bangkok, Thailand.泰国曼谷一家三级护理医院中耐碳青霉烯类肺炎克雷伯菌的碳青霉烯酶基因多样性
Acta Microbiol Immunol Hung. 2025 Jun 10;72(2):119-126. doi: 10.1556/030.2025.02599. Print 2025 Jun 20.
3
Antibacterial efficacy of cefoperazone/sulbactam in combination with various antimicrobials against carbapenem-resistant Klebsiella pneumoniae.头孢哌酮/舒巴坦联合多种抗菌药物对耐碳青霉烯类肺炎克雷伯菌的抗菌疗效
Acta Microbiol Immunol Hung. 2025 Apr 23;72(2):106-112. doi: 10.1556/030.2025.02577. Print 2025 Jun 20.
4
Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis.头孢他啶-阿维巴坦与其他抗菌药物治疗碳青霉烯类耐药肺炎克雷伯菌引起的感染的疗效和安全性:系统评价和荟萃分析。
Microb Pathog. 2023 Jun;179:106090. doi: 10.1016/j.micpath.2023.106090. Epub 2023 Mar 31.
5
Antimicrobial resistance and phylogenetic lineages of KPC-2-producing blood-borne subsp. from Kolkata, India during 2015-2024: Emergence of subsp. with , , and triple carbapenemases.2015年至2024年期间来自印度加尔各答的产KPC-2血源亚种的抗菌药物耐药性和系统发育谱系:具有NDM-1、IMP-1和VIM-2三重碳青霉烯酶的亚种的出现。
Microbiol Spectr. 2025 Jun 12:e0012625. doi: 10.1128/spectrum.00126-25.
6
In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.塞尔维亚某大学医院血培养中碳青霉烯类耐药肺炎克雷伯菌对亚胺培南/雷巴他定和头孢他啶/阿维巴坦的体外活性。
Acta Microbiol Immunol Hung. 2023 Aug 3;70(3):187-192. doi: 10.1556/030.2023.02108. Print 2023 Sep 21.
7
Improved diagnostic stewardship in carbapenem-resistant gene detection helps in early initiation of targeted therapy.改善耐碳青霉烯类基因检测中的诊断管理有助于早期启动靶向治疗。
J Med Microbiol. 2025 Jun;74(6). doi: 10.1099/jmm.0.002029.
8
Detection of different carbapenemases and clonality analysis of carbapenem-resistant Enterobacter cloacae.耐碳青霉烯类阴沟肠杆菌不同碳青霉烯酶的检测及克隆性分析
Acta Microbiol Immunol Hung. 2025 May 22;72(2):113-118. doi: 10.1556/030.2025.02604. Print 2025 Jun 20.
9
An update on carbapenem-resistant Enterobacterales: A prospective study from Western India.耐碳青霉烯类肠杆菌科细菌的最新情况:来自印度西部的一项前瞻性研究。
J Postgrad Med. 2025 Apr 1;71(2):61-67. doi: 10.4103/jpgm.jpgm_558_24. Epub 2025 Jun 9.
10
Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant Isolates in Shanghai.上海耐碳青霉烯类抗生素分离株的耐药表型和分子流行病学研究。
Microb Drug Resist. 2021 Oct;27(10):1312-1318. doi: 10.1089/mdr.2020.0390. Epub 2021 Jul 23.